Press Releases

Press Releases

New functionality provides a straightforward method for radiologists to indicate the first imaging test, or sign or symptom that triggered subsequent workup and diagnosis of breast cancer

Apollo introduces a groundbreaking new eBook, Delivering relevant medical images across the continuum of care, which introduces a paradigm shift in enterprise imaging, explaining how a multi-disciplinary, patient-centric approach supports thinking beyond the radiology workflow to reflect both the workflows of other specialties and medical encounters.

Patients and Physicians in Northeast Florida have been demanding a new type of patient-centric healthcare service. By partnering with Idonia, Precision Imaging Centers is answering that demand.

 

TIMS Medical releases TIMS MVP 5.0, a major new upgrade to its flagship product for recording, editing and archiving MBS, FEES and endoscopy studies in high-resolution video with synced audio.

Orthoscan announced the End of Life (EOL) plan for its Orthoscan FD, FD-OR, Mobile DI (MDI), and FD Pulse Mini C-Arms. 

Ascelia Pharma AB (publ) (ticker: ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced the successful completion of patient enrollment in the company’s pivotal phase 3 clinical study, SPARKLE, with the lead candidate drug Orviglance®.

When using this service, patients have the ability to upload and share data without limitations. From radiology CDs to PDFs or JPG files, patients can use their smartphone connected to the Patient Image Exchange app and upload images, share lab results, immunizations records, nurses’ notes, dental images and much more.

 

Award-winning company expands its U.S. warehouse with high-quality Mini C-Arm refurbishment center.

Nov 29, 2022 | Submitted by: Ascelia Pharma

23 November 2022: Ascelia Pharma AB (publ) – a biopharmaceutical company focused on improving the life of people living with rare cancer conditions –  is presenting results from its Orviglance* Food Effect study at the RSNA conference 2022 (Radiological Society of North America – 27 November – 1 December Chicago, Illinois). The study evaluates the effect of food intake on the absorption and signal intensity of Orviglance, a manganese-based MRI contrast agent, and successfully concludes that image enhancement is not impacted by a light meal.

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that it has partnered with Cerner Corporation to develop a dynamic clinical documentation solution. The solution will leverage evidence-based ProVation® Clinic Note content and clinical decision support which, when embedded with Cerner Millennium®, will guide physician documentation and capture critical information at the point of care.

Data presented here yesterday during the Late Breaking Clinical Trials session at VIVA13 show that a stent with unique three dimensional helical geometry, BioMimics 3D™, developed by Veryan Medical Ltd., (Horsham, UK) has demonstrated safety and promising clinical performance at twelve months in the treatment of patients with peripheral arterial disease (PAD) undergoing femoropopliteal artery intervention. 

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States (U.S.) Food and Drug Administration (FDA) granted accelerated approval of a Perjeta (pertuzumab) regimen for neoadjuvant treatment (use before surgery) in people with high-risk, HER2-positive early stage breast cancer. This approval is based primarily on data from a Phase II study showing that nearly 40 percent of people receiving the combination of Perjeta, Herceptin (trastuzumab) and docetaxel chemotherapy had no evidence of tumour tissue detectable at the time of surgery (known as a pathological complete response, or pCR). The Perjeta regimen is the first neoadjuvant breast cancer treatment approved by the FDA and also the first to be approved based on pCR data.

Konica Minolta Medical Imaging announces that the U.S. Food and Drug Administration (FDA) has cleared the Aero DR 10 x 12 wireless plate for sale.  This new plate is an ideal solution for sites seeking a smaller and lighter wireless flat panel for use in general X-ray and in specialty applications where smaller is just the right size, such as orthopedics and pediatrics. This includes the NICU where the Aero DR 10 x 12 detector fits most basinets and can be used with all major portable X-ray systems from various manufacturers. 

Shimadzu Medical Systems USA and the AHRA Education Foundation are pleased to announce a five year partnership extending through 2017 as part of the foundation’s Expanding Excellence Campaign.

The increasing importance and number of radiological images in clinical trials has raised technical and methodological issues for CROs globally. To make trials more efficient and ensure compliance, syneed medidata GmbH, an independent CRO in Germany, has signed a Master Services Agreement with Boston’s AG Mednet.

CIVCO Medical Solutions, the leading provider of radiation oncology motion management solutions, is pleased to announce U.S. Food and Drug Administration 510(k) clearance of ProturaTM Robotic Patient Positioning System integration with Varian Medical Systems’ Motion Management Interface.

Matakina International today announced that ProMedica Breast Care on the campus of ProMedica Toledo Hospital became the first in Ohio to offer VolparaDensity™ breast imaging software, designed to help overcome the limitations of mammography to detect cancer in women with dense breasts. Serving Northwest Ohio and Southeast Michigan, the Toledo Hospital Breast Care Center is the region’s premier imaging facility devoted exclusively to patients with breast health concerns and issues and has been named a Breast Imaging Center of Excellence by the American College of Radiology.

Increased awareness of the importance of mammography screening and new imaging modalities that can help with early detection are vital tools in the continuing battle against breast cancer, notes Anne Richards, Carestream's Clinical Development Manager for Women's Healthcare.<http://www.carestream.com/womenshealthcare.html>

Has your job search stalled? Do you not know where to send your resume? MiracleWorkers.com, a division of CareerBuilder, along with Economic Modeling Specialists International (EMSI) has released a list of Hot Jobs for Health Care, based on occupations with the greatest job increase between 2010 and 2013.

In a new report from Sectra, 78 referring physicians and 78 radiologists share their views on the process of ordering studies and communicating results.

Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has acquired from Datascope Corp. the SAFEGUARD(R) Pressure Assisted Device, which assists in obtaining and maintaining hemostasis after a femoral procedure, and the AIR-BAND(TM) Radial Compression Device, which is indicated to assist hemostasis of the radial artery puncture site while maintaining visibility.

Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has acquired the assets of Radial Assist, which include the RAD BOARD(R), RAD BOARD(R)XTRA(TM), RAD TRAC(TM), and RAD REST(R) devices.

The Medical Imaging & Technology Alliance (MITA) today applauded President Obama, Senate Majority Leader Harry Reid (D-NV), House Speaker John Boehner (R-OH), Energy and Natural Resources Committee Chair Senator Ron Wyden (D-OR), Committee Ranking Member Senator Lisa Murkowski (R-AK), House Natural Resources Committee Chair Representative Richard  “Doc” Hastings (R-WA), former Committee Ranking Member Senator Edward Markey (D-MA) and current Ranking Member Peter DeFazio (D-OR) for working together to sign the Responsible Helium Administration and Stewardship Act into law (H.R. 527) and prevent the premature closure of the Federal Helium Reserve.

Lexmark International, Inc. (NYSE: LXK) today announced the acquisition of PACSGEAR, a leading provider of connectivity solutions for healthcare providers to capture, manage and share medical images and related documents and integrate them with existing picture archiving and communication systems (PACS) and electronic medical records (EMR) systems. Lexmark paid a cash purchase price of approximately $54 million.

OrthoSensor announced today plans to launch its VERASENSE Knee System in European markets after recently receiving CE Mark approval. VERASENSE is the first integrated intelligent orthopaedic device to provide surgeons with real-time quantitative data on knee implant positioning, limb alignment and soft tissue balance during total knee replacement surgery.

EIZO Corporation (TSE: 6737) and Stryker Corporation have announced their partnership to offer customers integrated large monitor management systems suitable for use in standard and hybrid operating rooms.

As Moore and other communities in Oklahoma continue to struggle in the aftermath of the devastating storms this past May, FUJIFILM Medical Systems U.S.A., Inc. and FUJIFILM SonoSite, Inc. are helping families receive medical attention through donated equipment and supplies.  Both companies contributed medical imaging equipment at a total market value of $198,500 USD to Norman Regional Health Foundation, which will assist Norman Regional Health System (NRHS) with the overflow of patients resulting from the devastation at nearby Moore Medical Center.

The ScottCare Corporation announces the introduction of Innovo, a rechargeable digital transmitter for the company’s VersaCare multi-parameter telemetry solution serving cardiopulmonary rehabilitation clinics throughout the U.S. and internationally. ScottCare will feature the Innovo unit in Booth #607 at this year’s Annual Meeting of the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) in Nashville, Tenn., October 3-5, 2013.

UltraSPECT, a leading provider of image reconstruction technology that reduces radiopharmaceutical dose and acquisition time for nuclear medicine (NM) exams, announces today that study data has shown UltraSPECT solutions are a viable method for meeting American Society of Nuclear Cardiology (ASNC) low dose guidelines. Furthermore, technologists are able to rely on their existing imaging protocols, providing added confidence in overall results. UltraSPECT will be demonstrating this solution to conference attendees at the upcoming ASNC Annual Meeting, September 26-29, in Chicago.

Royal Philips (NYSE: PHG AEX: PHIA) and Accenture (NYSE: ACN) today announced the creation of a proof-of-concept demonstration that uses a Google Glass™ head-mounted display for researching ways to improve the effectiveness and efficiency of performing surgical procedures. The demonstration connects Google Glass to Philips IntelliVue Solutions and proves the concept of seamless transfer of patient vital signs into Google Glass, potentially providing physicians with hands-free access to critical clinical information.